IPCA LABORATORIES
Back to Balance Sheet
|
IPCA LABORATORIES Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹249 Cr | ₹235 Cr | ₹119 Cr | ₹93 Cr | ₹70 Cr |
What is the latest Contingent Liabilities ratio of IPCA LABORATORIES ?
| Year | Contingent Liabilities |
|---|---|
| Mar2026 | ₹249 Cr |
| Mar2025 | ₹235 Cr |
| Mar2024 | ₹119 Cr |
| Mar2023 | ₹93 Cr |
| Mar2022 | ₹70 Cr |
How is Contingent Liabilities of IPCA LABORATORIES Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹249 Cr | 6.10 | |
| Mar2025 | ₹235 Cr | 97.16 | |
| Mar2024 | ₹119 Cr | 27.48 | |
| Mar2023 | ₹93 Cr | 34.12 | |
| Mar2022 | ₹70 Cr | - | |
Compare Contingent Liabilities of peers of IPCA LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| IPCA LABORATORIES | ₹49,723.9 Cr | -0.7% | 2.3% | 49.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹457,073.0 Cr | 7.3% | 8.4% | 13.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹307,147.0 Cr | 15.3% | 24.1% | 63% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹181,626.0 Cr | 1% | 2.5% | 33.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹115,685.0 Cr | 1% | 15.9% | 14% | Stock Analytics | |
| CIPLA | ₹113,589.0 Cr | 0.4% | 7.9% | -6.2% | Stock Analytics | |
IPCA LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| IPCA LABORATORIES | -0.7% |
2.3% |
49.9% |
| SENSEX | 5.5% |
13.3% |
-3.4% |
You may also like the below Video Courses